cambridge september-12-09
TRANSCRIPT
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 1
Benefits and insights 2 years after implementation of NAVA and NIV NAVA as a standard of care…
Torben Steensgaard Andersen, MD, MHIT, Consultant
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 2
Conflict of interest
Maquet Critical Care has defrayed my expenses of hotels, flights etc for this lecture Maquet Critical Care has granted the Dept. of Anaesthesiology at Vejle Hospital for time used for hospital record reviews in connection with the study
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 3
• PRESENTATION
• IMPLEMENTATION STRATEGIES (what we did)
• RESULTS (if any !!)
• A FEW CASES
• WHAT’S NEXT IN NAVA? or
• If I could wish
Vejle Hospital
- a part of Lillebaelt Hospital
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 5
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 6
Facts and Figures
KEY FIGURES
• App. 62,000 inpatients with a mean length of stay of 3,7 days
• 463,800 outpatient attendances
• App. 700 beds • App. 4,500 members of staff (full time) • 2 ICUs with a total of 24 beds
Vejle Hospital
Specialized in diagnostics, treatment and care of cancer
KEY FIGURES 22.000 ward patients 250.000 outpatients 21.000 visits in ER
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 7
Key specialities • Cardiology • General Surgery • Haematology • Oncology • Orthopedic surgery • Neurology • Ear, Nose and Throat Surgery
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 8
Intensive Care Unit • 9 beds • 6 beds (intermediary/’step-up-step-down’)
Staff • 3 Senior Consultants • 1 Head Nurse • 70 nurses • Fellows/Senior Registrars/RMO/Interns
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 9
Key figures
• 1000 admissions per year • 400 admissions for intermediary • 200 treatments with ventilator • 250 treatments with NIV • 35 treatments with CRRT • Nurse-Patient Ratio
• 1 : 1 daytime • 0.8 : 1 nighttime and weekends
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 10
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 11
PHILOSOPHY SINCE 2004: • Actively participating patient • Low sedation strategy • Early mobilization • Spontaneous breathing
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 12
• PRESENTATION
• IMPLEMENTATION STRATEGIES (what we did)
• RESULTS (if any !!)
• A FEW CASES
• WHAT’S NEXT IN NAVA? or
• If I could wish
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 13
• IMPLEMENTATION
”Step-by-step” The goal is known, but the order
established during implementation
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 18
PREPARATION AND EDUCATION TIME:
2 MONTHS
FROM FEBRUARY 1st TO APRIL 1st 2014
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 20
HOW DID WE EDUCATE? • 2-3 hours theoretical education for all staff • Constantly bed-side training for juniors and nurses • A ”Weekly Focus” patient • Repeatedly discussed on weekly staffmeetings
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 21
Since April 1st 2014: ALL patients with respiratory insufficiency shall have an Edi catheter EXCEPT Patients who are expected to be without need for support within 12-24 hours Patients with known hiatal/esophageal hernia Patients with known bleeding disorders in oesophagus Patients who are treated with therapeutic hypothermia
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 22
PHILOSOPHY SINCE 2014: • Monitor respiratory capacity with Edi • Ventilate with NAVA if possible
(invasive or non-invasive)
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 23
• PRESENTATION
• IMPLEMENTATION STRATEGIES (what we did)
• RESULTS (if any !!)
• A FEW CASES
• WHAT’S NEXT IN NAVA? or
• If I could wish
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 24
• RETROSPECTIVE ANALYSIS
• A QUESTIONNAIRE
• SEMI-STRUCTURED INTERVIEWS
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 25
1 8 m o n t h s
1 8 m o n t h s
versus
A
B
NO NAVA (n = 114) NAVA (n = 43)
NO NAVA (n = 86) NAVA (n = 68)
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 26
A B versus
No differences in: • Speciality (medical/surgical/neurology/cardiology/haematology) • Gender • Age • Diagnoses • Reintubation • BMI • Initial bloodgases
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 27
NO NAVA (n = 114) NAVA (n = 43)
Time ( AVG hours)
Mechanical ventilation 31 112
Sedation with remifentanil 19 85
Use of norepinephrine 24 33
A
NO NAVA (n = 86) NAVA (n = 68)
23 76
21 49
23 44
B
Mortality n (%) n (%)
Dead in the ICU 20 (18) 13 (30)
Dead in 30 days 20 (18) 6 (14)
Dead in 90 days 8 (7) 6 (14)
Alive at 90 days 66 (58) 18 (42)
n (%) n (%)
10 (12) 19 (28)
12 (14) 15 (22)
3 (3) 1 (1)
61 (71) 33 (48)
Scores
APACHE II 23 25
SAPS II 45 51
21 27
41 49
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 29
PATIENT CHARACTERISTICS COMPARED FOR 3 GROUPS COMBINING THE 2 TIME PERIODS: • PATIENTS WITHOUT ANY NAVA-TREATMENT • PATIENTS RECEIVING NAVA FOR MORE THAN 50% OF VENTILATOR TIME • PATIENTS RECEIVING NAVA FOR LESS THAN 50% OF VENTILATOR TIME
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 30
NO NAVA (n = 200) NAVA < 50% (n =51) NAVA ≥ 50% (n =60)
Time (hours AVG)
Mechanical ventilation 42 79 79
Sedation with remifentanil 20 71 65
Use of norepinephrine 24 36 42
p
< 0.001
< 0.001
0.02
Mortality
Dead in the ICU 30 (15%) 19 (37%) 13 (22%)
Dead in 30 days 32 6 15
Dead in 90 days 11 2 5
Alive at 90 days 127 24 27
0.007
ns
ns
ns
Scores
APACHE II 22 28 25
SAPS II 43 51 49
< 0.001
< 0.01
LOS ICU 68 134 139 < 0.001
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 31
STAFF EXPERIENCES - A QUESTIONNAIRE
52 nurses and 18 physicians completed the survey
Majority > 10 years’ of experience as a professional
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 32
STAFF EXPERIENCES - A QUESTIONNAIRE
RESULTS
Advantages • Faster correction of respiratory insufficiency (58%) • Monitoring of respiratory capacity (42%) • Decreased ventilator time (29%) • Increased patient comfort (80%) • Increased patient involvement (33%) • Other (8%)
Disadvantages • Applying a particular nasogastric tube (40%) • Need for training in the NAVA modus (35%) • Troublesome to adjust correctly (15%) • Demands more in regard to collaboration with the patient (25%) • Other (25%)
• (this included the heaviness of the NG tube and short cabling)
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 33
STAFF EXPERIENCES - A QUESTIONNAIRE
RESULTS
84% found to a high or very high degree that NAVA is an excellent therapy option 79% experienced no barriers in regard to NAVA therapy Those experiencing barriers found that the main ones were
• Lack of experience for both nurses and physicians • Difficulties interpreting the alarms • The lack of control of most respiratory parameters
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 34
STAFF EXPERIENCES - semi-structured interviews
3 senior and 1 junior physician 2 senior nurses and 1 junior nurse
Advantages of NAVA • Increased patient comfort • Increased synchrony with the ventilator • Improved opportunities for monitoring patient respiratory performance
The implementation • The implementation had overall been very succesful • With a united commitment from physicians and nurses to move forward with
NAVA the implementation proces accelerated
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 35
STAFF EXPERIENCES - semi-structured interviews
The main barriers • Lack of knowledge • Uncertainty about NAVA • Lack of courage to skip the control over the patients ventilation • The time and effort needed to find the right setting for the individual patient
• (the triangle between patient, physician and ventilator)
Suggestions for improving implementation • Educating more ”Super-NAVA-nurses and -doctors” • Ensure expert knowlegde in the ICU 24/7 • Structured peer-to-peer training in practice • More education to especially senior physicians used to traditional respiratory
therapy (!)
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 36
• PRESENTATION
• IMPLEMENTATION STRATEGIES (what we did)
• RESULTS (if any !!)
• A FEW CASES
• WHAT’S NEXT IN NAVA? or
• If I could wish
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 37
Female 70 years old COPD - now pneumonia with hypoxia and hypercapnia. pH 7.19 Initially and for 18 hours ventilated with NIV-PS/PC without correcting her blodgasses Placing af Edi catheter
CASE I
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 41
Female 70 years old COPD - now pneumonia with hypoxia and hypercapnia. pH 7.19 Initially and for 18 hours ventilated with NIV-PS/PC without correcting her blodgasses Placing af NAVA catheter. After 8 minutes there is a perfect patient-ventilator synchronisation followed by rapid correction of blodgasses and normalization of pH.
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 42
Male 60 years old COPD. Skizophrenia. Found unconscious. pH 7.29 PaCO2 12 kPa. Initially ventilated with NIV-PS for several hours without correction of bloodgases Placing af Edi catheter
CASE II
Demonstrating asynchrony
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 46
Male 60 years old COPD. Skizophrenia. Found unconscious. pH 7.29. PaCO2 12 kPa Initially ventilated with NIV-PS Asynchrony Placing af NAVA catheter Immediate synchronisation. Correcting pH in 1 hour to 7.34 and PaCO2 9 kPa
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 47
Male 57 yo Weight 120 kg (BMI 39) Skizophrenia and COPD. Found laying on the floor - probably for the last 24 hours. Severe pneumonia and septic shock
CASE III
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 48
FiO2 = 0.6
PaO2/FiO2 = 170
pH = 7.18
PaCO2 = 8.7
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 51
FiO2 from 0.6 to 0.35
PaO2/FiO2 from170 to 225
pH from 7.18 to 7.43
PaCO2 from 8.7 to 5.4
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 52
Male 57 yo Weight 120 kg (BMI 39) Skizophrenia and COPD. Found laying on the floor - probably for the last 24 hours. Severe pneumonia and septic shock Rapid correction of blood gases, reduction of FiO2, improvement of P/F-fraction and ready for extubation or NIV
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 53
Male 80 yo Previously fit and healthy Subdural hematoma Evacuated Pneumonia Respiratory insufficiency Ventilator weaning
CASE IV
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 55
Part of procedure - given 40 mg propofol at 13.40
Note the reduction in Edi peak from 11 to 2.6 and the patients
ability to breath with very little diaphragmatic effort ….
..perfectly breathing with PS/CPAP ?
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 56
Male 80 yo Previously fit and healthy Subdural hematoma Evacuated Pneumonia Respiratory insufficiency Ventilator weaning
Think about:
Spontaneously breathing patient but without diaphragmatic effort
Monitor your sedation by means of the Edi-signal
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 57
CASE V
Male 72 yo Known with diabetes, aortic stenosis, cerebral shunt(hydrocephalus). Intracerebral hemorrhage -> Evacuated -> Pneumonia Respiratory insufficiency Transferred from University Hospital to our ICU at day 6 with a report saying that: “The patient is unable to breath sufficiently when we have tried to let him breath spontaneously”
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 59
• Placing a Edi catheter • Changing the mode to PC/PS • “Starving” the patient by reducing Pressure Control
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 60
Primary result: Spontaneously breathing without any work from the diaphragm
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 61
“Starving” the patient even more by reducing pressure support to 4:
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 62
50 minutes later perfectly and spontaneously breathing
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 64
Male 72 yo Known with diabetes, aortic stenosis, cerebral shunt(hydrocephalus). Intracerebral hemorrhage -> Evacuated -> Pneumonia Respiratory insufficiency Transferred from University Hospital to our ICU at day 6 with a report saying that he couldn’t breath sufficiently when they tried to let him breath spontaneously
Think about:
Hyperventilated patients often don’t breath spontaneously.
Monitor your ventilation by means of the Edi-signal
CASE V
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 65
CASE VI
Male 73 yo Previously fit and healthy Was still working as a teacher Sudden aphasia and lack of motor control. Rushed to thrombolytic therapy but proved ineffective. Thrombectomy was attempted but was abandoned due to bilateral stenosis in aa. vertebrae
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 66
9 days after insult and tracheostomy transferred to center for neural rehabilitation and ventilator weaning. 7 days after the transferral without need for ventilator in daytime and ventilator was discontinued. The following night cardiac arrest probably due to ventilatory arrest/insufficiency and hypoxaemia. 2 weeks later transferred to Vejle ICU - still in need of respiratory support at a low level (PS 11 cmH2O, PEEP 7 cmH2O, FiO2 0.28)
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 67
An Edi catheter was applied and detected normal diaphragmatic activity in the awake patient.
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 68
Normal diaphragmatic activity while the patient is awake - ventilated with PS/CPAP
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 69
During sleep however, all innervation of the diaphragm ceased, testifying that the patient's respiratory drive was exclusively relying on voluntary muscle contractions.
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 70
An MRI was performed, which revealed sequelae after a massive ischemic event near the brainstem of recent date confirming the suspicion evoked during ventilator therapy.
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 71
Male 73 yo Previously fit and healthy Was still working as a teacher Sudden aphasia and lack of motor control. Rushed to thrombolytic therapy but proved ineffective. Thrombectomy was attempted but was abandoned due to bilateral stenosis in aa. vertebrae
The Edi-signal as a diagnostic tool
Detection of Acquired Central Hypoventilation Syndrome (Ondine’s Curse) in an elderly male by means of monitoring with neurally adjusted ventilatory assist.
CASE VI
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 72
A few keypoints: • Implement as a ”Big Bang”
• Be sure that the staff is (very) well educated • Be sure you have NAVA-expertise 24/7/365 • Speed up the implementation by a united commitment from physicians and nurses • More education to especially senior physicians used to traditional respiratory
therapy!
• If you need proving your results • Design a prospective trial
• Use NAVA for
• Correcting asynchrony • Monitoring sedation • Rapid correction of ventilatory parameters • Monitoring your patients diaphragmatic activity • NAVA is
• ”Driving a car by looking out the front window instead of by looking in the rear mirror”
• A supplementary diagnostic tool in neurological diseases such as ”Ondine’s Curse, ALS, critical illness polyneuropathy
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 73
Some other insights • For both nurses and doctor has this high level
technology changed focus to basal, human physiology
• Personalized and spontaneous breathing is alpha
and omega for better comfort, reduced ventilator days and very fast weaning
NAVA-Symposium Cambridge 2016-09-12 Torben Steensgaard Andersen 74
• PRESENTATION
• IMPLEMENTATION STRATEGIES (what we did)
• RESULTS (if any !!)
• A FEW CASES
• WHAT’S NEXT IN NAVA? or
• If I could wish